Company Description
SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers in Japan, Vietnam, and internationally.
The company offers advertising and marketing services; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals and facility rentals; construction and design of franchisee clinics; medical equipment; and medical consumables procurement.
It provides breast augmentation, liposuction, and rejuvenation treatments, including treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods.
The company was founded in 2000 and is based in Irvine, California.
Country | United States |
Founded | 2000 |
Contact Details
Address: 200 Spectrum Center Drive, Suite 300 Irvine, California 92618 United States | |
Phone | 949-593-0250 |
Website | sbc-holdings.com |
Stock Details
Ticker Symbol | SBC |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001930313 |
ISIN Number | US73245B1070 |
Employer ID | 88-1263511 |
SIC Code | 8011 |
Key Executives
Name | Position |
---|---|
Mark Caranci | Chief Executive Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Sep 24, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
Sep 23, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
Sep 23, 2024 | SC 13D | General statement of acquisition of beneficial ownership |
Sep 20, 2024 | 8-K | Current Report |
Sep 19, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
Sep 18, 2024 | 25-NSE | Filing |
Aug 29, 2024 | 8-K | Current Report |
Aug 23, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Aug 23, 2024 | 8-K | Current Report |
Aug 20, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |